Durvalumab Alone or in Combination With Novel Agents in Subjects With NSCLC
Completed · Phase 2
Conditions studied: Stage III Non-small Cell Lung Cancer, Unresectable
In brief
The purpose of this study is to compare the clinical activity of durvalumab alone vs durvalumab in combination with novel agents. The overall study goal is early identification of novel durvalumab combinations that are more active than durvalumab alone in the treatment of patients with unresectable, Stage III NSCLC who have not progressed after cCRT.
Key facts
- Study ID
- NCT03822351
- Run by
- MedImmune LLC
- People needed
- 189
- Starts
- 2018-12-19
- Expected to finish
- 2023-07-18
- Last updated by the study team
- 2024-10-08
Who can join
Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Research Site — Duarte, California, United States
- Research Site — Sacramento, California, United States
- Research Site — New Haven, Connecticut, United States
- Research Site — West Haven, Connecticut, United States
- Research Site — Washington D.C., District of Columbia, United States
- Research Site — Orlando, Florida, United States
- Research Site — Winter Haven, Florida, United States
- Research Site — Wichita, Kansas, United States
- Research Site — Lexington, Kentucky, United States
- Research Site — Louisville, Kentucky, United States
- Research Site — Baton Rouge, Louisiana, United States
- Research Site — Covington, Louisiana, United States
- Research Site — Rosedale, Maryland, United States
- Research Site — Lincoln, Nebraska, United States
- Research Site — New York, New York, United States
- Research Site — New York, New York, United States
- Research Site — Portland, Oregon, United States
- Research Site — Gettysburg, Pennsylvania, United States
- Research Site — Lancaster, Pennsylvania, United States
- Research Site — Philadelphia, Pennsylvania, United States
- Research Site — Sioux Falls, South Dakota, United States
- Research Site — Germantown, Tennessee, United States
- Research Site — Memphis, Tennessee, United States
- Research Site — Tyler, Texas, United States
- Research Site — Anaheim, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.